COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?

被引：0
|
作者：
Autore, Francesco [1 ]
Visentin, Andrea [2 ]
Deodato, Marina [3 ]
Vitale, Candida [4 ]
Galli, Eugenio [1 ]
Fresa, Alberto [1 ]
Fazzi, Rita [5 ]
Sanna, Alessandro [6 ]
Olivieri, Jacopo [7 ]
Scortechini, Ilaria [8 ]
Principe, Maria Ilaria Del [9 ]
Sportoletti, Paolo [1 ,10 ,11 ]
Innocenti, Idanna [1 ]
Coscia, Marta [4 ]
Tedeschi, Alessandra [3 ]
Trentin, Livio [2 ]
Candoni, Anna [12 ]
Busca, Alessandro [4 ]
Pagano, Livio [1 ,2 ,13 ]
Laurenti, Luca [1 ,13 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Lab & Infettivolog, Rome, Italy
[2] Univ Padua, Dept Med, Hematol Unit, Padua, Italy
[3] ASST Grande Osped Metropolitano Niguarda, Div Hematol, Milan, Italy
[4] AOU Citta Salute Sci Torino, Div Hematol, Turin, Italy
[5] Azienda Osped Univ Pisana, UO Ematol, Pisa, Italy
[6] Azienda Osped Univ Careggi, Dept Oncol, Hematol Unit, Florence, Italy
[7] Azienda Sanit Univ Friuli Cent, Clin Ematol Udine, Udine, Italy
[8] Azienda osped Univ Marche, Clin Ematol, Ancona, Italy
[9] Univ Roma Tor Vergata, Dipartimento Biomed Prevenz, Rome, Italy
[10] Univ Perugia, Inst Hematol, Dept Med & Surg, AO Santa Maria della Misericordia Perugia, Perugia, Italy
[11] Univ Perugia, Ctr Hemato Oncol Res CREO, AO Santa Maria della Misericordia Perugia, Perugia, Italy
[12] Univ Modena & Reggio Emilia, Dept Med & Surg Sci, Sect Haematol, Modena, Italy
[13] Univ Cattolica Sacro Cuore, Dipartimento Diagnost Immagini Radioterapia Oncolo, Dipartimento Diagnostica Immagini, Rome, Italy
来源：
BLOOD ADVANCES | 2025年 / 9卷 / 01期
关键词：
D O I：
10.1182/bloodadvances.2024013792
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：162 / 165
页数：4
相关论文
共 50 条
  • [31] CHANGES IN SERUM COMPLEMENT ACTIVITY DURING ANTI-CD20 AND ANTI-CD52 MONOCLONAL ANTIBODY THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Stasilojc, Grzegorz
    Felberg, Anna
    Taszner, Michal
    Urban, Aleksandra
    Ma, Shuo
    Blom, Anna
    Lundin, Jeanette
    Osterborg, Anders
    Okroj, Marcin
    MOLECULAR IMMUNOLOGY, 2019, 114 : 415 - 415
  • [32] Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
    Ogura, Michinori
    Hatake, Kiyohiko
    Tobinai, Kensei
    Uchida, Toshiki
    Suzuki, Tatsuya
    Terui, Yasuhito
    Yokoyama, Masahiro
    Maruyama, Dai
    Mori, Masakazu
    Jewell, Roxanne C.
    Katsura, Koichi
    Hotta, Tomomitsu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (05) : 466 - 475
  • [33] Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia
    Roberts, Andrew W.
    Stilgenbauer, Stephan
    Seymour, John F.
    Huang, David C. S.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4527 - 4533
  • [34] Immunological Response to COVID-19 Vaccine Boosters in Multiple Sclerosis Patients Treated with anti-CD20 Therapy
    De Oliveira, Antonia
    Lei, Joyce
    Liu, Jiayuan
    Roche, Morgan
    Lin, Jerry
    Alfonso, Roberto
    Sadiq, Saud
    NEUROLOGY, 2023, 100 (17)
  • [35] Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises
    Bagacean, Cristina
    Zdrenghea, Mihnea
    Tempescul, Adrian
    Cristea, Victor
    Renaudineau, Yves
    IMMUNOTHERAPY, 2016, 8 (05) : 569 - 581
  • [36] COVID-19 in Patients with Chronic Lymphocytic Leukemia - What Have We Learned?
    Harel, Reut
    Itchaki, Gilad
    ACTA HAEMATOLOGICA, 2024, 147 (01) : 62 - 74
  • [37] Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases
    Zaja, F
    Vianelli, N
    Sperotto, A
    Patriarca, F
    Tani, M
    Marin, L
    Tiribelli, M
    Candoni, A
    Baccarani, M
    Fanin, R
    LEUKEMIA & LYMPHOMA, 2003, 44 (11) : 1951 - 1955
  • [38] Activity and Safety of Venetoclax without Anti-CD20 Lead-in Therapy in Treatment Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia
    Pleyer, Christopher
    Tomasulo, Emily
    Superata, Jeanine
    Adams, Rachel
    Tian, Xin
    Grey, Jayson
    Nierman, Pia
    Wiestner, Adrian
    Sun, Clare
    BLOOD, 2024, 144 : 4623 - 4623
  • [39] Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia
    Adamo, Francesco Maria
    Barcelos, Estevao Carlos Silva
    De Falco, Filomena
    Dorillo, Erica
    Rompietti, Chiara
    Sorcini, Daniele
    Stella, Arianna
    Del Papa, Beatrice
    Baldoni, Stefano
    Esposito, Angela
    Geraci, Clelia
    Arcaleni, Roberta
    Pennetta, Chiara
    Ragonese, Francesco
    Moretti, Lorenzo
    Mameli, Mariagrazia
    Di Ianni, Mauro
    Rosati, Emanuela
    Fioretti, Bernard
    Sportoletti, Paolo
    CANCERS, 2023, 15 (14)
  • [40] Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Retrospective, Single-Institution Analysis Based on Risk Features and Debulking Strategy with Anti-CD20 Monoclonal Antibody
    Grajales-Cruz, Ariel F.
    Chavez, Julio
    Volpe, Virginia Olivia
    Sandoval-Sus, Jose
    Shah, Bijal
    Bello, Celeste
    Sokol, Lubomir
    Fisher, Shanel
    Nair, Rajesh R.
    Seongseok, Yun
    Saeed, Hayder
    Isenalumhe, Leidy
    Turba, Elyce P.
    Nodzon, Lisa
    Ibarz, Javier Pinilla
    BLOOD, 2019, 134
12345